CasemoreDP, WrightSE, CoopRL. Cryptosporidiosis – human and animal epidemiology. In: Fayer, op. cit. ref. 1, 65–92.
4.
CasemoreDP. Epidemiological aspects of human cryptosporidiosis. Epidemiol Infect1990; 104:1–28.
5.
CasemoreDP. Molecular and antigenic aspects of Cryptosporidium and cryptosporidiosis (a brief review). In: BouchierI, chairman. Cryptosporidium in water supplies Third report of the group of experts to Department of Environment, Transport and the Regions & Department of Health. DETR; 1998; 137–42. (See also http://www.dwi.detr.gov.uk
6.
GasserRB, O'DonoghueP. Isolation, propagation and characterization of Cryptosporidium. Int J Parasitol1999; 29:1379–413.
7.
CasemoreDP, WarrellDA. Cryptosporidium and crypto-sporidiosis. In: WeatherallDJ, LedinghamJGG, WarellDA, editors. Oxford Textbook of MedicineOxford: OUP; 1996; 869–76.
MorganUM, SargentKD, DeplazesP. Molecular characterization of Cryptosporidium from various hosts. Parasitology1998; 117:31–7.
10.
PatelS, Pedraz-DiazS, McLauchlinJ. Molecular characterization of Cryptosporidium parvum from two large waterborne outbreaks. Commun Dis Public Health1998; 4:231–3.
11.
PieniazekNJ, Bornay-LlinaresJ, SlemendaSB. New Cryptosporidium genotypes in HIV-infected persons. Emerg Infect Dis1999; 5:444–9.
12.
CasemoreDP. Cryptosporidium and the safety of our water supplies. Commun Dis Public Health1998; 4:218–9.
13.
Bouchierop. cit. ref.5.
14.
Petersen, C. Cryptosporidiosis in patients infected with the human immunodeficiency virus. Clin Infect Dis 1992; 15:903–9.
15.
VakilNB, SchwartzSM, BuggyBP. Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee. N Engl J Med1995; 334:19–23.
16.
SharpstoneD, GazzardB. Gastrointestinal manifestations of HIV infection. Lancet1996; 348:379–83.
17.
LamadueJA, ManabeYC, MooreRD. A clinicopathalogic analysis of AIDS-related cryptosporidiosis. AIDS1998; 12:2459–66.
18.
SteinerTS, GuerrantRL. The pathogenesis of the host response to Cryptosporidium parvum. Curr Opin Infect Dis1996; 9:156–60.
19.
ClarkDP, SearsCL. Reviews. The pathogenesis of cryptosporidiosis. Parasitol Today1996; 12:221–5.
GriffithsJK, MooreR, DooleyS. Cryptosporidium parvum infection of CaCo-2 cell monolayer induces an apical monolayer defect, selectively increases transmonolayer permeability, and cause epithelial cell death. Infect Immun1994; 62:4506–14.
22.
GuarinoA, CananiRB, CasolaA. Human intestinal cryptosporidiosis: secretory diarrhea and enterotoxic activity in CaCo-2 cells. J Infect Dis1995; 171:976–83.
23.
LaurentF, KagnoffMF, SavidgeTC. Human intestinal epithelial cells respond to Cryptosporidium parvum infection with increased prostaglandin H synthase 2 expression and prostaglandin E2 and F2α production. Infect Immun1998; 66:1787–90.
24.
MølbakK, HøjlyngN, GottschauA. Cryptosporidiosis in infancy and childhood mortality in Guinea Bissau, West Africa. BMJ1993; 307:417–20.
25.
AgnewDG, LimaAAM, NewmanRD. Cryptosporidiosis in northeastern Brazilian children: association with increased diarrhea morbidity. J Infect Dis1998; 177:754–60.
26.
ChecklyW, GilmanRH, EpsteinLD. Asymptomatic and symptomatic cryptosporidiosis: their acute effect on weight gain in Peruvian children. Am J Epidemiol1997; 145:156–63.
27.
GoodgameRW, KimballK, OuC-N. Intestinal function and injury in acquired immunodeficiency syndrome-related cryptosporidiosis. Gastroenterology1995; 108:1075–82.
28.
LimaAAM, SilvaTMJ, GifoniAMR. Mucosal injury and disruption of intestinal barrier function in HIV-infected individuals with and without diarrhea and cryptosporidiosis in northeast Brazil. Am J Gastroenterol1997; 92:1861–6.
29.
KellyP, DaviesSE, MandandaB. Enteropathy in Zambians with HIV related diarrhoea: regression modelling of potential determinants of mucosal damage. Gut1997; 41:811–6.
30.
KotlerDP. Human immunodeficiency virus-related wasting: malabsorption syndromes. Semin Oncol1998; 25:70–5.
31.
MwachariC, BatchelorBIF, PaulJ. Chronic diarrhoea among HIV-infected adult patients in Nairobi, Kenya. J Infect1998; 37:48–53.
32.
BeaugerieL, CarbonnelF, CarratF. Factors of weight loss in patients with HIV and chronic diarrhea. J Acquir Immune Defic Syndr Hum Retrovirol1998; 19:34–9.
33.
McDonaldV, BancroftGJ. Immunological control of Cryptosporidium infection. Chem Immunol1998; 70:103–23.
34.
ColfordJM, TagerIB, HirozawaAM. Cryptosporidiosis among patients infected with the human immunodeficiency virus. Am J Epidemiol 1996 144:903–9
35.
ChaissonRE, GallantJE, KerulyJC. Impact of opportunistic disease on survival in patients with HIV infection. AIDS1998; 12:29–33.
36.
DannSM, OkhuysenPC, SalamehBM. Fecal antibody to Cryptosporidium parvum in healthy volunteers. Infect Immun2000; 68:5068–74.
37.
MølbakK, AabyP, HøjlyngN. Risk factors for Cryptosporidium diarrhea in early childhood: a case-control study from Guinea-Bissau, West Africa. Am J Epidemiol1994; 139: 734–40.
38.
GreenbergPD, CelloJP. Treatment of severe diarrhoea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. J Acquir Immun Defic Syndr Hum Retrovirol1996; 13:348–54.
39.
OkhuysenPC, ChappellCL, CrabbJ. Prophylactic effect of bovine anti- Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum. Clin Infect Dis1998; 26:1324–9.
40.
KuhlsLK, MosierDA, CrawfordDL. Seroprevalence of cryptosporidial antibodies during infancy, childhood, and adolescence. Clin Infect Dis1994; 18:731–5.
41.
McLauchlinJ, CasemoreDP, MoranS. The epidemiology of cryptosporidiosis: application of experimental sub-typing and antibody detection systems to the investigation of waterborne outbreaks. Folia Parasitol1998; 45:8392.
42.
OngCSL, EislerCL, GohSH. Molecular epidemiology of cryptosporidiosis outbreaks and transmission in British Columbia, Canada. Am J Trop Med Hyg1999; 61:63–9.
43.
OkhuysenPC, ChappellCL, SterlingCR. Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum. Infect Immun1998; 66:441–3.
44.
CaputoC, ForbesA, FrostF. Determinants of antibody to Cryptosporidium infection among gay and bisexual men with HIV infection. Epidemiol Infect1999; 122:291–7.
45.
PalmerSR, BiffinA. Cryptosporidiosis in England and Wales: prevalence and clinical and epidemiological features. BMJ1990; 300:774–7.
46.
CasemoreDP. Broadsheet No 128: The laboratory diagnosis of human cryptosporidiosis. J Clin Pathol1991; 44:445–51.
47.
ChappellCL, OkhuysenPC, SterlingCR. Cryptosporidium parvum: intensity of infection and oocyst excretion patterns in healthy volunteers. J Infect Dis1996; 173:232–6.
48.
GreenbergPD, KochJ, CelloJP. Diagnosis of Cryptosporidium parvum in patients with severe diarrhoea and AIDS. Dig Dis Sci1996; 41:2286–90.
49.
TanyükselMT, GünH, DoganciL. Prevalence of Cryptosporidium sp. In patients with neoplasia and diarrhea. Scand J Infect Dis1995; 27:69–70.
50.
ManabeYC, ClarkDP, MooreRD. Cryptosporidiosis in patients with AIDS: correlates of disease and survival. Clin Infect Dis1998; 27:536–42.
51.
ClavelA, ArnalAC, SánchezEC. Respiratory cryptosporidiosis: case series and review of the literature. Infection1996; 24:341–6.
52.
CasemoreDP, RobertsC. Guidelines for screening for Cryptosporidium in stools: report of a joint working group. J Clin Pathol1993; 46:2–4.
53.
HoepelmanAIM. Current therapeutic approaches to cryptosporidiosis in immunocompromised patients. J Antimicrob Chemother1996; 37:871–80.
54.
BlagburnBL, SoaveR. Prophylaxis and chemotherapy: human and animal. In: Fayer R, op. cit. ref. 1, 113–30.
55.
Blanchard C, Shanson DC, Gazzard BG. Pilot study of azithrocin, letrazuril and paromomycin in the treatment of cryptosporidiosis. Int J STD AIDS 1997; 8:124–9.
56.
SmithNH, CronS, ValdezLM. Combination drug therapy for cryptosporidiosis in AIDS. J Infect Dis1998; 178:900–3.
57.
FoudraineNA, WeverlingGJ, VanGoolT. Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy. AIDS1998; 12:35–41.
58.
MiaoYM, Awad-El-KariemFM, GibbonsCL. Cryptosporidiosis: eradication or suppression with combination antiretroviral therapy?AIDS1999; 13:734–5.
59.
CordellRL, AddissDG. Cryptosporidiosis in childcare settings: a review of the literature and recommendations for prevention and control. Pediatr Infect Dis J1994; 13:310–7.
60.
SmithHV, RoseJB. Reviews. Waterborne cryptosporidiosis: current status. Parasitol Today1998; 14:14–22.
61.
MeinhardtPL, CasemoreDP, MillerKB. Epidemiologic aspects of human cryptosporidiosis and the role of waterborne transmission. Epidemiol Rev1996; 18:118–36.
62.
FurtadoC, AdakGK, StuartJM. Outbreaks of waterborne infectious intestinal disease in England and Wales, 1992–5. Epidemiol Infect1998; 121:109–19.
63.
RoseJB, SlifkoTR. Giardia, Cryptosporidium, and Cyclospora and their impact on foods – a review. J Food Prot1999; 62:1059–70
64.
GirdwoodRWA, SmithHV. Cryptosporidium. In: Robinson RK, Batt CA, Patel PD, editors. Encyclopaedia of Food MicrobiologyLondon: Academic Press, 2000;487–502.
65.
PedersenC, DannerS, LazzarinA. Epidemiology of cryptosporidiosis among European AIDS patients. Genitourin Med1996; 71:128–31.
66.
MatosO, TomásA, AguiarP. Prevalence of cryptosporidiosis in AIDS patients with diarrhoea in Santa Maria Hospital, Lisbon. Folia Parasitol1998; 45:163–6.
67.
TompkinsDS, HudsonMJ, SmithHR. A study of infectious intestinal disease in England: microbiological findings in cases and controls. Commun Dis Public Health1999; 2:108–13.
68.
CasemoreDP, GardnarCA, O'MahoneyM. Cryptosporidial infection, with special reference to nosocomial transmission of Cryptosporidium parvum: a review. Folia Parasitol1994; 41:17–21.
69.
BlewettDA, WrightSE, CasemoreDP. Infective dose studies on Cryptosporidium parvum using gnotobiotic lambs. Wat Sci Tech1993; 27:61–4.
70.
DuPontHL, ChappellCL, SterlingCR. The infectivity of Cryptosporidium parvum in healthy volunteers. N Engl J Med1995; 332:855–9.
71.
OkhuysenPC, ChappellCL, CrabbJH. Virulence of three distinct Cryptosporidium parvum isolates for healthy adults. J Infect Dis1999; 180:1275–81.
72.
CasemoreDP, WatkinsJ. Review of disinfection and associated studies on Cryptosporidium. Report prepared for the DETR Drinking Water Inspectorate. DETR;1999;56fp.
HoltenJ, ShettyN, McDonaldV. Efficacy of ‘Nu-Cidex’ (0·35% peracetic acid) against mycobacteria and cryptosporidia. J Hosp Infect1995; 31:235–44.
75.
WilsonJA, MargolinAB. The efficacy of three common hospital liquid germicides to inactivate Cryptosporidium parvum oocysts. J Hosp Infect1999; 42:231–7.
76.
JuranekDD. Cryptosporidiosis: sources of infection and guidelines for prevention. Clin Infect Dis1995; 21:S57–61.
77.
HeathcockR, McLauchlinJ, NewtonLH. Short Report. Survey of food safety awareness among HIV-positive individuals. AIDS Care1998; 10:237–41.